05/18/2016 |
Near-infrared photoimmunotherapy uses an antibody-photoabsorber conjugate that binds to cancer cells. When near-infrared light is applied, the cells swell and then burst, causing the cancer cell to die. Photoimmunotherapy is in clinical trials in patients with inoperable tumors. For more information, please visit www.cancer.gov/ |
jueves, 19 de mayo de 2016
Killing Cancer Cells with the Help of Infrared Light - Photoimmunotherapy
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario